Graça, N. A. G., Gaspar, L., Costa, D. M., Loureiro, I., et al. (2016). Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei. Antimicrobial Agents and Chemotherapy, 60(4), 2532 - 2536.

Moreira, D., Silvestre, R., Cordeiro-da-Silva, A., Estaquier, J., et al. (2016). AMP-activated protein kinase as a target for pathogens: Friends or foes?. Current Drug Targets, 17(8), 942 - 953.

Mesquita, I., Moreira, D., Sampaio-Marques, B., Laforge, M., et al. (2016). AMPK in Pathogens. EXS, 107, 287 - 323.

Tavares, J., Ouaissi, A., Silva, A. M., Lin, P. K. T., et al. (2012). Anti-leishmanial activity of the bisnaphthalimidopropyl derivatives. Parasitology International, 61(2), 360 - 363.

Santarém, N., Silvestre, R., Cardoso, L., Schallig, H., et al. (2010). Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis. Journal of Clinical Microbiology, 48(5), 1866 - 1874.

Borges, O., Silva, M., de Sousa, A., Borchard, G., et al. (2008). Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen. International Immunopharmacology, 8(13-14), 1773 - 1780.

Cardoso, L., Schallig, H. D. F. H., Cordeiro-da-Silva, A., Cabral, M., et al. (2007). Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs. Veterinary Immunology and Immunopathology, 117(1-2), 35 - 41.

Santarém, N., Tomás, A., Ouaissi, A., Tavares, J., et al. (2005). Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunology Letters, 101(1), 18 - 23.